2022-2030 年按类型(体外、体内)、按产品(试剂和耗材、化验、服务)、按应用、按地区、按细分市场划分的基因毒性测试市场规模、份额、趋势分析报告
市场调查报告书
商品编码
1133325

2022-2030 年按类型(体外、体内)、按产品(试剂和耗材、化验、服务)、按应用、按地区、按细分市场划分的基因毒性测试市场规模、份额、趋势分析报告

Genetic Toxicology Testing Market Size, Share & Trends Analysis Report By Type (In-vitro, In-vivo), By Product (Reagents & Consumables, Assays, Services), By Application, By Region, And Segment Forecasts, 2022 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

基因毒性测试市场的增长和趋势

根据 Grand View Research, Inc. 的一份新报告,到 2030 年,全球基因毒理学检测市场预计将达到 35.7 亿美元。从 2022 年到 2030 年,市场预计将以 12.7% 的复合年增长率增长。随着全球细胞和基因疗法的发展,越来越多地使用个性化药物,增加了对基因毒性的需求。例如,美国 FDA 已经为细胞和基因治疗製造商制定了指导文件。根据该指南,在临床前研究中确定毒性和生理参数的信息将有助于指导研究药物的临床监测。

越来越多地使用个性化医疗和采用药物遗传学来帮助降低药物毒性的风险预计将对行业的发展产生重大影响。此外,荷兰药物遗传学工作组(DPWG)、临床药物遗传学实践联盟(CPIC)、法国药物遗传学国家网络和加拿大药物遗传学网络(CPNDS)等组织都在倡导药物遗传学检测,并发布临床指南专注于特定药物基因对的解释和治疗建议。

同样,市场公司正在沉迷于各种策略,以扩大其在多个领域的足迹。例如,2021 年 11 月,Labcorp 宣布收购提供非临床测试服务的合同研究组织 (CRO) Toxikon。此次收购预计将加强 Labcorp 的毒理学业务,而 Toxikon 的位置将为 Labcorp 提供与该地区知名生物技术和製药公司的非临床合作。

预计 COVID-19 大流行将对基因毒性测试市场的增长产生中性影响。许多研究人员利用基因毒性来评估药物对 COVID-19 病毒的功效。例如,2020 年 9 月,一组研究人员评估了氯奎 (CQ) 和羟氯奎 (HCQ) 作为病毒预防剂的作用。我们评估了各种药物和化学品的遗传毒性。此类研究使用遗传毒性测试作为评估工具,预计将支持 COVID-19 高峰期间的稳定增长。

对新型食品及其进口的需求不断增长,预计将有助于市场增长。Charles River Laboratories 是新型食品毒理学评估的领先供应商之一。他们提供新颖的食品分析,包括遗传毒性,包括体内微核试验、Ames 试验、体外哺乳动物细胞微核和体内彗星试验。同样,2021 年 1 月,EFSA 发布了对昆虫食品的评估。这是该机构对昆虫产品作为一种新型食品进行的首次此类评估。EFSA 每年都会收到数十份申请,其中包括基于藻类食品、植物和非本地水果的草药产品。

另一方面,通过基因毒理学提取信息是有限的。根据病理学测试评论组织,基因测试提供有关特定疾病或正在测试的基因的信息。它不包括有关可能存在的其他未经测试的遗传疾病的信息。同样,它不能识别导致疾病的基因中的所有突变,也不能表明疾病的严重程度。因此,预计这些限制将阻碍基因毒理学行业的发展。

遗传毒理学检测市场报告亮点

按类型划分,预计 2021 年体外基因毒性检测市场份额最大,增长最快。由于食品行业对基因毒性的监管要求不断提高

通过应用,製药和生物技术部门估计是市场的主要贡献者。这是由于细胞和基因治疗、药物基因组学的发展以及越来越多地使用个性化医疗。

由于新型食品进口增加和检验法规收紧,尤其是在澳大利亚,预计亚太地区在预测期内将显着增长。

从产品来看,随着製药和生物技术公司对非临床试验的需求增加,服务业将在 2021 年占据很大份额。合同研究机构的战略举措增加也是一个关键的增长动力

由于存在满足製药和生物技术公司需求的高效参与者,北美是 2021 年基因毒理学的关键区域市场。个性化医疗的研发增加也是一个主要因素。

主要市场参与者包括 Thermo Fisher Scientific, Inc.、Charles River Laboratories International、Laboratory Corp of America Holdings 和 Eurofins Scientific。

目录

第一章研究方法论

  • 市场细分和范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR内部数据库
    • 次要信息
    • 初步调查
    • 初步调查详情
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法一:商品流动方法
      • 方法 2:使用自下而上的方法按国家/地区进行市场预测
  • 全球市场:复合年增长率计算
  • 调查假设
  • 二级信息列表
  • 主要信息列表
  • 目的
  • 缩略语表

第二章市场定义

第三章执行摘要

  • 市场概况

4 全球基因毒性测试市场:变量、趋势和范围

  • 基因毒性测试市场的谱系展望
    • 母公司市场展望
  • 绘製渗透率和增长前景
  • 监管框架
  • 市场驱动力分析
    • 细胞和基因治疗的发展
    • 越来越多地使用药物基因组学和个性化医疗
    • 新食品进口增加
  • 市场约束因素分析
    • 对保险合同的模糊规定
    • 提供有限信息的能力
  • COVID-19 影响分析
  • 波特五力分析
  • SWOT分析

5 基因毒性测试市场:细分分析,按类型,2018-2030 年(百万美元)

  • 全球基因毒性测试市场:变异分析
  • 体外
  • 体内

6. 基因毒性测试市场:细分分析,按产品,2018-2030 年(百万美元)

  • 全球基因毒性测试市场:产品变异分析
  • 试剂和耗材
  • 化验
  • 服务

7. 基因毒性测试市场:细分分析,按应用,2018-2030 年(百万美元)

  • 基因毒性测试市场:应用变异分析
  • 製药和生物技术
  • 食品工业
  • 化妆品行业
  • 其他

8. 2018-2030 年基因毒性检测市场:细分分析,按地区划分(百万美元)

  • 基因毒性检测市场:区域变异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 意大利
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第 9 章 竞争格局

  • 上市公司
    • 公司市场分析
    • 竞争仪錶盘分析
    • 战略框架
  • 民营企业
    • 关键初创企业/技术颠覆者/创新者名单
    • 区域网络图
  • 公司简介
    • Thermo Fisher Scientific, Inc
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • CHARLES RIVER LABORATORIES INTERNATIONAL
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Laboratory Corp of America Holdings
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • EUROFINS SCIENTIFIC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • JUBILANT LIFE SCIENCES LIMITED
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • SYNGENE INTERNATIONAL LIMITED
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • GENTRONIX LTD.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • INOTIV INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • CREATIVE BIOARRAY
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • MB RESEARCH LABORATORIES
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-981-3

Genetic Toxicology Testing Market Growth & Trends:

The global genetic toxicology testing market size is expected to reach USD 3.57 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 12.7% from 2022 to 2030. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product.

Increasing implementation of pharmacogenomics to support personalized medicine usage and reduced risk of adverse drug toxicity is considered to have a significant impact on the growth of the industry. Moreover, organizations, such as the Dutch Pharmacogenetics Working Group (DPWG), Clinical Pharmacogenetics Implementation Consortium (CPIC), the French National Network of Pharmacogenetics, and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), have issued clinical guidelines with a primary focus on the pharmacogenomics testing interpretation and recommendation on therapeutic specific drug-gene pairs.

Similarly, the market players are indulging in various strategies to expand their footprint in multiple segments. For instance, in November 2021, Labcorp announced the acquisition of Toxikon, a Contract Research Organization (CRO) with offerings in nonclinical testing services. Through this acquisition, Labcorp is anticipated to strengthen its toxicology business and Toxikon's location enables Labcorp to engage with known biotech and pharmaceutical companies in the region for non-clinical work.

The COVID-19 pandemic is anticipated to have a neutral impact on the genetic toxicology testing market growth. Numerous researchers employed genotoxic to assess the effects of drugs against the COVID-19 virus. For instance, in September 2020, a team of researchers evaluated the impact of Chloroquine (CQ) and Hydroxychloroquine (HCQ) as prophylactic drugs against the virus. The genetic toxicology of various drugs and chemicals was assessed. Such studies using genetic toxicology testing as a tool of assessment are anticipated to support stable growth during the peak of COVID-19.

The rising demand for novel food and its imports is expected to be a contributor to market growth. Charles River Laboratories is one of the major players offering toxicology assessments on novel foods. They offer novel food analysis including genotoxicity, which consist of in vivo micronucleus test, Ames study, In Vitro Mammalian Cell Micronucleus, and in the vivo comet assay. Similarly, in January 2021, EFSA published its evaluation of insect-derived food. It is the first kind of assessment conducted by the institution on the insect product as a novel food. Every year, EFSA receives a large number of applications, consisting of herbal products based on algae foods, plants, and non-indigenous fruits.

On the other hand, the ability to retrieve information through genetic toxicology is limited. According to the Pathology Tests Explained organization, genetic tests offer information regarding the specific diseases/gene that is being tested. It does not cover information about other genetic diseases that might be present but have not been tested. Similarly, it cannot identify all the variations of genes that cause the diseases, and also it does not showcase the severity of the diseases. Hence, these limitations are anticipated to hamper the growth of the genetic toxicology industry.

Genetic Toxicology Testing Market Report Highlights:

  • By type, the in vitro is expected to be the fastest growing segment with the largest share of the Genetic Toxicology Testing Market in 2021. Owing to the rising requirement by regulatory agencies for genotoxicity in the food industry
  • By application, the pharmaceutical & biotechnology segment is estimated to become a major market contributor. This is attributed to an increase in the development of cell and gene therapy, coupled with increasing use of pharmacogenomics and personalized medicines
  • The Asia Pacific region is projected to grow substantially over the forecasted period owing to the increasing imports of novel food and tightening test regulations for the same, especially in Australia
  • By product, the service segment captured a significant proportion of the share in 2021, owing to the increasing demand by pharmaceutical and biotechnology companies for nonclinical works. Also, increasing strategic initiatives by contract research organizations is a major growth determinant
  • North America was a major regional market for genetic toxicology in 2021 owing to the availability of efficient players in the region to match the demand by pharma and biotech companies. The increasing R&D in personalized medicines is also a significant factor
  • Some of the main market players include Thermo Fisher Scientific, Inc.; Charles River Laboratories International; Laboratory Corp of America Holdings; and Eurofins Scientific

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country - wise market estimation using a bottom - up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global Genetic Toxicology Testing Market Variables, Trends, & Scope

  • 4.1 Genetic Toxicology Testing Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Regulatory Framework
  • 4.4 Market Driver Analysis
    • 4.4.1 Development Of Cell And Gene Therapy
    • 4.4.2 Increasing Use Of Pharmacogenomics And Personalized Medicines
    • 4.4.3 Increasing Imports Of Novel Food
  • 4.5 Market Restraint Analysis
    • 4.5.1 Vague Regulations On Insurance Policy
    • 4.5.2 Ability To Offer Limited Information
  • 4.6 COVID - 19 Impact Analysis
  • 4.7 Porter's Five Forces Analysis
  • 4.8 SWOT Analysis

Chapter 5 Genetic Toxicology Testing Market - Segment Analysis, by type, 2018 - 2030 (USD Million)

  • 5.1 Global Genetic Toxicology Testing Market: Type Movement Analysis
  • 5.2 In Vitro
    • 5.2.1 In Vitro Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 In Vivo
    • 5.3.1 In Vivo Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Genetic Toxicology Testing Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 6.1 Global Genetic Toxicology Testing Market: Product Movement Analysis
  • 6.2 Reagents & Consumables
    • 6.2.1 Reagents & Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Assays
    • 6.3.1 Assays Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Services
    • 6.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Genetic Toxicology Testing Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 7.1 Genetic Toxicology Testing Market: Application Movement Analysis
  • 7.2 Pharmaceutical & Biotechnology
    • 7.2.1 Pharmaceutical & Biotechnology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Food Industry
    • 7.3.1 Food Industry Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Cosmetics Industry
    • 7.4.1 Cosmetics Industry Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4. Other
    • 7.4.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Genetic Toxicology Testing Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Genetic Toxicology Testing Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Spain
      • 8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 France
      • 8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea market estimates and forecast, 2018 - 2030
    • 8.4.6 Australia
      • 8.4.6.1 Australia market estimates and forecast, 2018 - 2030
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Public Companies
    • 9.1.1 Company Market Position Analysis
    • 9.1.2 Competitive Dashboard Analysis
    • 9.1.3 Strategic Framework
  • 9.2 Private Companies
    • 9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 9.2.2 Regional Network Map
  • 9.4 Company Profiles
    • 9.4.1 Thermo Fisher Scientific, Inc
      • 9.4.1.1 Company Overview
      • 9.4.1.2 Financial Performance
      • 9.4.1.3 Product Benchmarking
      • 9.4.1.4 Strategic Initiatives
    • 9.4.2 CHARLES RIVER LABORATORIES INTERNATIONAL
      • 9.4.2.1 Company Overview
      • 9.4.2.2 Financial Performance
      • 9.4.2.3 Product Benchmarking
      • 9.4.2.4 Strategic Initiatives
    • 9.4.3 Laboratory Corp of America Holdings
      • 9.4.3.1 Company Overview
      • 9.4.3.2 Financial Performance
      • 9.4.3.3 Product Benchmarking
      • 9.4.3.4 Strategic Initiatives
    • 9.4.4 EUROFINS SCIENTIFIC
      • 9.4.4.1 Company Overview
      • 9.4.4.2 Financial Performance
      • 9.4.4.3 Product Benchmarking
      • 9.4.4.4 Strategic Initiatives
    • 9.4.5 JUBILANT LIFE SCIENCES LIMITED
      • 9.4.5.1 Company Overview
      • 9.4.5.2 Financial Performance
      • 9.4.5.3 Product Benchmarking
      • 9.4.5.4 Strategic Initiatives
    • 9.4.6 SYNGENE INTERNATIONAL LIMITED
      • 9.4.6.1 Company Overview
      • 9.4.6.2 Financial Performance
      • 9.4.6.3 Product Benchmarking
      • 9.4.6.4 Strategic Initiatives
    • 9.4.7 GENTRONIX LTD.
      • 9.4.7.1 Company Overview
      • 9.4.7.2 Financial Performance
      • 9.4.7.3 Product Benchmarking
      • 9.4.7.4 Strategic Initiatives
    • 9.4.8 INOTIV INC.
      • 9.4.8.1 Company Overview
      • 9.4.8.2 Financial Performance
      • 9.4.8.3 Product Benchmarking
      • 9.4.8.4 Strategic Initiatives
    • 9.4.9 CREATIVE BIOARRAY
      • 9.4.9.1 Company Overview
      • 9.4.9.2 Financial Performance
      • 9.4.9.3 Product Benchmarking
      • 9.4.9.4 Strategic Initiatives
    • 9.4.10 MB RESEARCH LABORATORIES
      • 9.4.10.1 Company Overview
      • 9.4.10.2 Financial Performance
      • 9.4.10.3 Product Benchmarking
      • 9.4.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Genetic Toxicology Testing Market, by Product 2018 - 2030 (USD Million)
  • Table 5 Global Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Genetic Toxicology Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 U.S. Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 Canada Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 16 Canada Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 17 Europe Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 Europe Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 21 Germany Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Germany Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Germany Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 U.K. Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 U.K. Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 U.K. Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 27 France Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 France Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 France Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Italy Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Italy Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Italy Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Spain Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Spain Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 China Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 41 China Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 42 China Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Japan Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 44 Japan Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Japan Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 46 India Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 India Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 India Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 49 South Korea Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 South Korea Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 South Korea Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Australia Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 Australia Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Australia Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Latin America Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 56 Latin America Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 57 Latin America Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 58 Latin America Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 Brazil Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 60 Brazil Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 Brazil Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Mexico Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 63 Mexico Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Mexico Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Argentina Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 66 Argentina Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Argentina Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 68 Middle East & Africa Genetic Toxicology Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 69 Middle East & Africa Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 70 Middle East & Africa Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 72 South Africa Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 73 South Africa Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 South Africa Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Saudi Arabia Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 UAE Genetic Toxicology Testing Market, by Type, 2018 - 2030 (USD Million)
  • Table 79 UAE Genetic Toxicology Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 UAE Genetic Toxicology Testing Market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Genetic Toxicology, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global Protein Expression Market: Type Movement Analysis
  • Fig. 17 Global Genetic Toxicology Testing Market, for In Vitro, 2018 - 2030 (USD Million)
  • Fig. 18 Global Genetic Toxicology Testing Market, for In Vivo, 2018 - 2030 (USD Million)
  • Fig. 19 Global Protein Expression Market: Product Movement Analysis
  • Fig. 20 Global Protein Expression Market, for Reagents & Consumables, 2018 - 2030 (USD Million)
  • Fig. 21 Global Genetic Toxicology Testing Market, for Assays, 2018 - 2030 (USD Million)
  • Fig. 22 Global Genetic Toxicology Testing Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 23 Global Protein Expression Market: Application Movement Analysis
  • Fig. 24 Global Genetic Toxicology Testing Market, for Pharmaceutical; Biotechnology, 2018 - 2030 (USD Million)
  • Fig. 25 Global Genetic Toxicology Testing Market, for Food Industry, 2018 - 2030 (USD Million)
  • Fig. 26 Global Genetic Toxicology Testing Market, for Cosmetics Industry, 2018 - 2030 (USD Million)
  • Fig. 27 Global Genetic Toxicology Testing Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 28 Regional Marketplace: Key Takeaways
  • Fig. 29 Regional Outlook, 2021 & 2030
  • Fig. 30 Global Genetic Toxicology Testing Market: Region Movement Analysis
  • Fig. 31 North America Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 37 France Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 39 Spain Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Japan Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 42 China Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 43 India Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 44 Australia Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Argentina Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 Middle East and Africa Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 UAE Genetic Toxicology Testing Market, 2018 - 2030 (USD Million)